Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Gap Up – Here’s What Happened

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) gapped up prior to trading on Tuesday. The stock had previously closed at $13.95, but opened at $14.97. Bayer Aktiengesellschaft shares last traded at $14.95, with a volume of 160,871 shares traded.

Analyst Ratings Changes

Separately, Zacks Research upgraded Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 10th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Stock Performance

The business has a fifty day simple moving average of $13.43 and a 200-day simple moving average of $12.55. The company has a quick ratio of 0.67, a current ratio of 1.04 and a debt-to-equity ratio of 1.05. The firm has a market cap of $58.75 billion, a P/E ratio of -29.31, a P/E/G ratio of 1.94 and a beta of 0.57.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last announced its earnings results on Tuesday, November 3rd. The company reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.02). Bayer Aktiengesellschaft had a negative net margin of 3.80% and a positive return on equity of 16.77%. On average, sell-side analysts predict that Bayer Aktiengesellschaft will post 1.27 EPS for the current fiscal year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft is a Germany-based life sciences company headquartered in Leverkusen. Founded in 1863 by Friedrich Bayer and Johann Friedrich Weskott, the company develops products in health care and agriculture and serves customers in markets around the world.

Bayer operates through three primary businesses: Pharmaceuticals, Consumer Health and Crop Science. Its Pharmaceuticals segment develops prescription medicines in areas such as cardiovascular disease, women’s health, oncology, hematology and specialty therapies.